top of page

Elmiron Drug Recall Lawsuit

Writer's picture: Jinks CrowJinks Crow


Elmiron is a brand name for an anticoagulant drug that is classified as low molecular weight heparin. The drug was approved by the Food and Drug Administration in 1996 for the treatment of interstitial cystitis, or IC. This is a condition affecting the bladder that results in chronic pain and impacts urinary frequency. Elmiron is the only approved oral pharmacological treatment for IC, but concerns have arisen about its side effects.


A 2018 report published by the Emory Eye Center indicated that long-term exposure might be toxic to the eye and damage sensitive retinal tissue. Subsequently, another report presented at the American Academy of Ophthalmology meeting in October 2019 also offered more evidence suggesting the bladder medication could result in a “vision-threatening” eye condition.


The 2019 evidence suggests as many as a quarter of patients who had “significant exposure” to the drug had developed signs of eye damage. Specifically, patients on Elmiron face a substantially increased risk of pigmentary maculopathy, retinal maculopathy or macular degeneration.


In January 2020, the first lawsuit against Janssen Pharmaceuticals was filed by affected individuals. The plaintiffs allege both that Elmiron caused unexpected damage to the eye resulting in vision impairment and that Janssen Pharmaceuticals may have been aware of the risk and withheld adverse event reports from the public and from the Food and Drug Administration.


Symptoms of an Elmiron Eye Injury

Elmiron use has been allegedly linked to three primary conditions, including pigmentary maculopathy, retinal maculopathy, and macular degeneration. Symptoms of an eye injury induced by Elmiron include:

  • Blurred vision

  • Distorted vision

  • Eye color changes

  • Increased sensitivity to light

  • Difficulty adjusting to the darkness

  • Difficulty reading

  • Muted colors

  • Straight lines appear curvy

  • Dark spots in your vision

  • Blind spots in your vision

  • Eye pain

  • Vision loss

Exposure to pentosan polysulfate sodium, Elmiron’s active ingredient, has been specifically identified as the sole cause of pigmentary maculopathy. If you are experiencing these symptoms and have been diagnosed with pigmentary maculopathy or a related condition, contact the Elmiron drug recall lawsuit lawyers at Jinks, Crow & Dickson regarding your potential claim.

Comments


Contact Us

For more than 40 years, the personal injury lawyers at Jinks Crow have been helping people who have been injured by the negligence of another person or company. Our personal injury attorneys have represented clients in successfully seeking compensation for their physical injuries, mental anguish, and emotional distress. If you or a loved one has been injured and you believe it was the fault of another person, contact us today to schedule a free and confidential consultation.

Thanks for contacting us!

Union Springs Office

219 North Prairie Street

Union Springs, Alabama 36089

Phone: (334) 738-4225

Toll Free: (888) 239-3040

Fax: (334) 738-4229

Montgomery Office

324 Catoma Street

Montgomery, Alabama 36104

Phone: (334) 738-4225

Toll Free: (888) 239-3040

Fax: (334) 738-4229

© 2024 by Jinks Crow, PC.

Website design by Cartography Consulting.

DISCLAIMER: The information presented on this website should not be construed to be formal legal advice nor the formation of a lawyer/client relationship. Therefore, no information of any kind that you provide us before such a relationship is created is confidential or privileged. These recoveries and testimonials are not an indication of future results. Every case is different, and regardless of what friends, family, or other individuals may say about what a case is worth, each case must be evaluated on its own facts and circumstances as they apply to the law. The valuation of a case depends on the facts, the injuries, the jurisdiction, the venue, the witnesses, the parties, and the testimony, among other factors. Furthermore, no representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

bottom of page